Search

Search results

100 results found

The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.

Ramchand, Sabashini K, Natalie L David, Hang Lee, Michael Bruce, Mary L Bouxsein, Joy N Tsai, and Benjamin Z Leder. 2023. “The Effect of Zoledronic Acid on Bone Microarchitecture and Strength After Denosumab and Teriparatide Administration: DATA-HD Study Extension.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 38 (1): 26-34.

Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project.

Schini, Marian, Tatiane Vilaca, Eric Vittinghoff, Li-Yung Lui, Susan K Ewing, Austin R Thompson, Douglas C Bauer, Mary L Bouxsein, Dennis M Black, and Richard Eastell. 2024. “Influence of Age on the Efficacy of Pharmacologic Treatments on Fracture Risk Reduction and Increases in BMD: RCT Results from the FNIH-ASBMR-SABRE Project.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 39 (5): 544-50.

Impact loading in female runners with single and multiple bone stress injuries during fresh and exerted conditions.

Popp, Kristin L, Jereme Outerleys, Sarah Gehman, Margaret Garrahan, Sara Rudolph, Elizabeth Loranger, Kathryn E Ackerman, Adam S Tenforde, Mary L Bouxsein, and Irene S Davis. 2023. “Impact Loading in Female Runners With Single and Multiple Bone Stress Injuries During Fresh and Exerted Conditions.”. Journal of Sport and Health Science 12 (3): 406-13.

The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project.

Vilaca, Tatiane, Marian Schini, Li-Yung Lui, Susan K Ewing, Austin R Thompson, Eric Vittinghoff, Douglas C Bauer, Richard Eastell, Dennis M Black, and Mary L Bouxsein. 2024. “The Relationship Between Treatment-Related Changes in Total Hip BMD Measured After 12, 18, and 24 mo and Fracture Risk Reduction in Osteoporosis Clinical Trials: The FNIH-ASBMR-SABRE Project.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 39 (10): 1434-42.